20416 Federal Register / Vol. 87, No. 67 / Thursday, April 7, 2022 / Notices 

the United States for more than 60 

days. 

llllllllllllPrint Name 

llllllllllllSignature 

lllllllDate 

Privacy Act Statement for Travelers 

Relating to the Requirement To Provide 

Proof of a Negative COVID–19 Test 

Result 

The U.S. Centers for Disease Control 

and Prevention (CDC) requires airlines 

and other aircraft operators to collect 

this information pursuant to 42 CFR 

71.20 and 71.31(b), as authorized by 42 

U.S.C. 264. Providing this information is 

mandatory for all passengers arriving by 

aircraft into the United States. Failure to 

provide this information may prevent 

you from boarding the plane. 

Additionally, passengers will be 

required to attest to providing complete 

and accurate information, and failure to 

do so may lead to other consequences, 

including criminal penalties. CDC will 

use this information to help prevent the 

introduction, transmission, and spread 

of communicable diseases by 

performing contact tracing 

investigations and notifying exposed 

individuals and public health 

authorities; and for health education, 

treatment, prophylaxis, or other 

appropriate public health interventions, 

including the implementation of travel 

restrictions. 

The Privacy Act of 1974, 5 U.S.C. 

552a, governs the collection and use of 

this information. The information 

maintained by CDC will be covered by 

CDC’s System of Records No. 09–20– 

0171, Quarantine- and Traveler-Related 

Activities, Including Records for 

Contact Tracing Investigation and 

Notification under 42 CFR parts 70 and 

71. See 72 FR 70867 (Dec. 13, 2007), as 

amended by 76 FR 4485 (Jan. 25, 2011) 

and 83 FR 6591 (Feb. 14, 2018). CDC 

will only disclose information from the 

system outside the CDC and the U.S. 

Department of Health and Human 

Services as the Privacy Act permits, 

including in accordance with the 

routine uses published for this system 

in the Federal Register, and as 

authorized by law. Such lawful 

purposes may include, but are not 

limited to, sharing identifiable 

information with state and local public 

health departments, and other 

cooperating authorities. CDC and 

cooperating authorities will retain, use, 

delete, or otherwise destroy the 

designated information in accordance 

with federal law and the System of 

Records Notice (SORN) set forth above. 

You may contact the system manager at 

dgmqpolicyoffice@cdc.gov or by mailing 

Policy Office, Division of Global 

Migration and Quarantine, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H16–4, Atlanta, 

GA 30329, if you have questions about 

CDC’s use of your data. 

Authority 

The authority for the Presidential 

Proclamation is Sections 1182(f) and 

1185(a)(1) of Title 8, and Section 301 of 

Title 3, United States Code. CDC’s Order 

is issued pursuant to the Presidential 

Proclamation. 

Sherri Berger, 

Chief of Staff, Centers for Disease Control 

and Prevention. 

[FR Doc. 2022–07450 Filed 4–4–22; 4:15 pm] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier CMS–224–14 and 

CMS–10305] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information (including each proposed 

extension or reinstatement of an existing 

collection of information) and to allow 

60 days for public comment on the 

proposed action. Interested persons are 

invited to send comments regarding our 

burden estimates or any other aspect of 

this collection of information, including 

the necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions, 

the accuracy of the estimated burden, 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected, and the use of automated 

collection techniques or other forms of 

information technology to minimize the 

information collection burden. 

DATES: Comments must be received by 

June 6, 2022. 

ADDRESSES: When commenting, please 

reference the document identifier or 

OMB control number. To be assured 

consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number: lll, Room C4–26– 

05, 7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ website address at 

website address at https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing. 

FOR FURTHER INFORMATION CONTACT: 

William N. Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: 

Contents 

This notice sets out a summary of the 

use and burden associated with the 

following information collections. More 

detailed information can be found in 

each collection’s supporting statement 

and associated materials (see 

ADDRESSES). 

CMS–224–14 Federally Qualified 

Health Center Cost Report Form 

CMS–10305 Medicare Part C and Part 

D Data Validation (42 CFR 422.516(g) 

and 423.514(j)) 

Under the PRA (44 U.S.C. 3501– 

3520), federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

The term ‘‘collection of information’’ is 

defined in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA 

requires federal agencies to publish a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, before 

submitting the collection to OMB for 

approval. To comply with this 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 67 / Thursday, April 7, 2022 / Notices 20417 

requirement, CMS is publishing this 

notice. 

Information Collection 

1. Type of Information Collection 

Request: Reinstatement without change 

of a previously approved collection; 

Title of Information Collection: 

Federally Qualified Health Center Cost 

Report Form; Use: The Form CMS–224– 

14 cost report is needed to determine a 

provider’s reasonable cost incurred in 

furnishing medical services to Medicare 

beneficiaries and to calculate the FQHC 

settlement amount. These providers, 

paid under the FQHC prospective 

payment system (PPS), may receive 

reimbursement outside of the PPS for 

Medicare reimbursable bad debts, 

pneumococcal, influenza, and COVID– 

19 vaccines, and monoclonal antibody 

products. CMS uses the Form CMS– 

224–14 for rate setting; payment 

refinement activities, including 

developing a FQHC market basket; 

Medicare Trust Fund projections; and to 

support program operations. 

Additionally, the Medicare Payment 

Advisory Commission (MedPAC) uses 

the FQHC Medicare cost report data to 

calculate Medicare margins; to 

formulate recommendations to Congress 

regarding the FQHC PPS; and to 

conduct additional analysis of the 

FQHC PPS. Form Number: CMS–224–14 

(OMB control number: 0938–1298); 

Frequency: Yearly; Affected Public: 

Private Sector, State, Local, or Tribal 

Governments, Federal Government, 

Business or other for-profits, Not-forProfit Institutions; Number of 

Respondents: 2,890; Total Annual 

Responses: 2,890; Total Annual Hours: 

167,620. (For policy questions regarding 

this collection contact LuAnn Piccione 

at 410–786–5423.) 

2. Type of Information Collection 

Request: Revision of a currently 

approved collection; Title of 

Information Collection: Medicare Part C 

and Part D Data Validation (42 CFR 

422.516(g) and 423.514(j)); Use: Sections 

1857(e) and 1860D–12 of the Social 

Security Act (‘‘the Act’’) authorize CMS 

to establish information collection 

requirements with respect to MAOs and 

Part D sponsors. Section 1857(e)(1) of 

the Act requires MAOs to provide the 

Secretary of the Department of Health 

and Human Services (DHHS) with such 

information as the Secretary may find 

necessary and appropriate. Section 

1857(e)(1) of the Act applies to 

Prescription Drug Plans (PDPs) as 

indicated in section1860D–12. Pursuant 

to statutory authority, CMS codified 

these information collection 

requirements in regulation at 

§§ 422.516(g) Validation of Part C 

Reporting Requirements, and 423.514(j) 

Validation of Part D Reporting 

Requirements respectively. 

Data collected via Medicare Part C 

and Part D reporting requirements are 

an integral resource for oversight, 

monitoring, compliance and auditing 

activities necessary to ensure quality 

provision of Medicare benefits to 

beneficiaries. CMS uses the findings 

collected through the data validation 

process to substantiate the data reported 

via Medicare Part C and Part D reporting 

requirements. Data validation provides 

CMS with assurance that plan-reported 

data are credible and consistently 

collected and reported by Part C and D 

SOs. CMS uses validated data to 

respond to inquiries from Congress, 

oversight agencies, and the public about 

Part C and D SOs. The validated data 

also allows CMS to effectively monitor 

and compare the performance of SOs 

over time. Validated plan-reported data 

may be used for Star Ratings, Display 

measures and other performance 

measures. Additionally, SOs can take 

advantage of the DV process to 

effectively assess their own performance 

and make improvements to their 

internal operations and reporting 

processes. Form Number: CMS–10305 

(OMB control number: 0938–1115); 

Frequency: Yearly; Affected Public: 

State, Local, or Tribal Governments; 

Number of Respondents: 793; Total 

Annual Responses: 793; Total Annual 

Hours: 21,535. (For policy questions 

regarding this collection contact 

Chanelle Jones at 410–786–8008.) 

Dated: April 4, 2022. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2022–07426 Filed 4–6–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; ORR–1, 

Cash and Medical Assistance Program 

Estimates 

AGENCY: Office of Refugee Resettlement, 

Administration for Children and 

Families, HHS. 

ACTION: Request for public comment. 

SUMMARY: The Office of Refugee 

Resettlement (ORR), Administration for 

Children and Families (ACF), U.S. 

Department of Health and Human 

Services (HHS) is requesting a 3-year 

extension of the form ORR–1, Cash and 

Medical Assistance Program Estimates 

(OMB #0970–0030, expiration 5/21/ 

2022). There are no changes requested 

to the form or instructions. 

DATES: Comments due within 30 days of 

publication. OMB must make a decision 

about the collection of information 

between 30 and 60 days after 

publication of this document in the 

Federal Register. Therefore, a comment 

is best assured of having its full effect 

if OMB receives it within 30 days of 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. You can also obtain 

copies of the proposed collection of 

information by emailing infocollection@

acf.hhs.gov. Identify all emailed 

requests by the title of the information 

collection. 

SUPPLEMENTARY INFORMATION: 

Description: The ORR–1, Cash and 

Medical Assistance Program Estimates, 

is the application for grants under the 

Cash and Medical Assistance (CMA) 

program. The application is required by 

ORR program regulations at 45 CFR 

400.11(b). The regulation specifies that 

states must submit, as their application 

for this program, estimates of the 

projected costs they anticipate incurring 

in providing cash and medical 

assistance for eligible recipients and the 

costs of administering the program. 

Under the CMA program, states are 

reimbursed for the costs of providing 

these services and benefits for 8 months 

after an eligible recipient arrives in this 

country. The eligible recipients for these 

services and benefits are refugees, 

Amerasians, Cuban and Haitian 

Entrants, asylees, Afghans and Iraqi 

with Special Immigrant Visas, and 

victims of a severe form of trafficking. 

States that provide services for 

unaccompanied refugee minors also 

provide an estimate for the cost of these 

services for the year for which they are 

applying for grants. 

Respondents: State Agencies, the 

District of Columbia, and Replacement 

Designees under 45 CFR 400.301(c) 

administering or supervising the 

administration of programs under Title 

IV of the Act. 


khammond on DSKJM1Z7X2PROD with NOTICES